Shares of International Biotechnology (LON:IBT – Get Free Report) crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 657.12 ($8.68) and traded as high as GBX 696.40 ($9.20). International Biotechnology shares last traded at GBX 694 ($9.17), with a volume of 56,388 shares.
International Biotechnology Stock Performance
The stock has a 50 day moving average price of GBX 685.39 and a two-hundred day moving average price of GBX 657.12. The company has a debt-to-equity ratio of 9.66, a current ratio of 0.46 and a quick ratio of 0.32. The company has a market capitalization of £256.50 million, a price-to-earnings ratio of 1,445.83 and a beta of 0.21.
International Biotechnology Increases Dividend
The business also recently declared a dividend, which was paid on Friday, August 23rd. Investors of record on Thursday, July 25th were issued a GBX 14.50 ($0.19) dividend. The ex-dividend date of this dividend was Thursday, July 25th. This represents a dividend yield of 2.28%. This is a positive change from International Biotechnology’s previous dividend of $13.90. International Biotechnology’s dividend payout ratio (DPR) is currently 6,041.67%.
Insider Activity
International Biotechnology Company Profile
International Biotechnology Trust plc specializes in investments in development stage and late stage companies. The majority of the fund's assets are generally invested in smaller and mid-capitalization quoted companies, with a minority in larger capitalization quoted companies. It makes long only investments.
Recommended Stories
- Five stocks we like better than International Biotechnology
- Financial Services Stocks Investing
- Analysts Predict 85% Upside for Wave Life Sciences After Rate Cut
- What Are Dividend Challengers?
- FedEx Stock Dips: Another Reason to Fear Recession Is Near
- The How And Why of Investing in Oil Stocks
- The Half-Penny Revolution: Will SEC’s Reform Benefit Investors?
Receive News & Ratings for International Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for International Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.